Smallpox vaccine gets funding from U.S. gov't for PhIII; Vaccine data to be presented as ASCO;

> Bavarian Nordic has received an extra $32 million from the U.S. government, which will support the Phase III trials of its smallpox vaccine, IMVAMUNE. Press release | Article

> AE37 breast cancer vaccine data will be presented at ASCO 2012. Press release

> Bavarian Nordic plans to present its PROSTVAC data at ASCO, too. Press release

> A newly-discovered protein interaction could be a new target for development of a broad-spectrum HPV vaccine. Press release

> A combination of a cancer vaccine and monoclonal antibodies was effective in a mouse model of glioma. Abstract

And Finally… Cancer vaccine company Tvax Biomedical has withdrawn its planned IPO because of "market conditions." Article

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.